Cardiovascular Drug Manufacturer in India

WHO-GMP certified cardiovascular medicine manufacturing across tablets, capsules and sterile injections — antihypertensives, diuretics, lipid-lowering agents, beta-blockers, antiarrhythmics and anticoagulants for domestic supply, institutional procurement and international export.

Key Highlights

WHO-GMP
Certified Facility
Oral
Sterile Injectable · Full CV Range
15+ Countries
Supplied
DCGI Approved
Formulations

Request A Product List

Download Capability Brochure

About Cardiovascular

Cardiovascular drug manufacturing
expertise at 9M India

9M India manufactures a comprehensive range of cardiovascular medicines from a WHO-GMP certified facility in Birkoni, Chhattisgarh. Our cardiovascular portfolio covers oral solid formulations (tablets and capsules) and sterile injectable cardiovascular preparations — spanning antihypertensives, diuretics, lipid-lowering agents, beta-blockers, anticoagulants and antiarrhythmics across the major cardiovascular drug classes.

Cardiovascular diseases represent the leading cause of mortality globally, and cardiovascular medicines are among the most consistently demanded categories in institutional supply, government procurement and long-term export contracts. Antihypertensive tablets — Amlodipine, Atenolol, Metoprolol — are core formulary items in every district hospital, medical college and government health programme. Statins — Atorvastatin, Rosuvastatin — are high- volume generic medicines with strong demand across domestic and export markets.

For critical care and emergency cardiovascular situations, injectable formulations including Labetalol (antihypertensive), Adenosine (antiarrhythmic) and Heparin (anticoagulant) are manufactured in our sterile classified cleanroom facility. Every cardiovascular formulation at 9M India carries a valid DCGI manufacturing licence with complete regulatory documentation.

Cardiovascular medicines across tablets, capsules and sterile injections
Antihypertensives, diuretics, lipid-lowering, beta-blockers, anticoagulants, antiarrhythmics
Critical care injectable cardiovascular formulations — Labetalol, Adenosine, Heparin
WHO-GMP certified with in-house QC and analytical testing
DCGI-approved — export-ready with complete regulatory documentation

Enquire Now

About Cardiovascular

Cardiovascular drug manufacturing
capabilities at 9M India

From antihypertensive tablet compression through statin film-coating to sterile cardiac injectable aseptic fill-finish — our cardiovascular manufacturing capability covers every production stage.

01

Amlodipine tablets (calcium channel blocker) — available in 2.5mg, 5mg and 10mg strengths with validated content uniformity at low-dose levels. Atenolol and Metoprolol tablets (beta-blockers) in standard and extended-release formats. Combination antihypertensive tablets — Amlodipine + Atenolol, Amlodipine + Valsartan and other fixed-dose antihypertensive combinations. All antihypertensive tablets manufactured with HPLC assay validation and in- process dissolution monitoring. Low-dose tablet manufacturing requires enhanced blend uniformity validation — conducted as standard for all cardiac formulations below 10mg strength.
02

Atorvastatin and Rosuvastatin tablets — the two most prescribed statins globally — manufactured in film-coated tablet format across multiple strengths. Statin tablets are sensitive to moisture, light and temperature — Alu-Alu cold form blister packaging is used as standard for all statin formulations to ensure shelf-life compliance. Dissolution testing using USP Apparatus 2 with photo-protection protocols is performed on every statin batch. Simvastatin and other statin formulations available on request.
03

Furosemide (loop diuretic) tablets — a core item in every hospital formulary and government tender list for heart failure and oedema management. Hydrochlorothiazide tablets (thiazide diuretic) — frequently combined with antihypertensives in fixed-dose combination tablets. Spironolactone tablets (potassium-sparing diuretic) for heart failure and hypertension. Diuretic formulations require validated dissolution across multiple pH conditions given the variable GI environment. All diuretic formulations are validated against relevant pharmacopoeial dissolution specifications.
04

Labetalol injection (combined alpha and beta-blocker) — antihypertensive emergency injectable for hypertensive crisis management. Adenosine injection (antiarrhythmic) — vial liquid for rapid-onset atrial arrhythmia management. Heparin injection (anticoagulant) — vial liquid in multiple strengths for venous thromboembolism prophylaxis and treatment. All sterile cardiac injectables manufactured in classified cleanroom environments with aseptic fill-finish, sterility testing, endotoxin testing and particulate matter analysis on every batch.
05

Cardiovascular medicines are core components of every state essential medicines list, CGHS formulary and institutional hospital procurement programme. All 9M India cardiovascular formulations are DCGI-approved and our documentation package — Manufacturing Licence, WHO-GMP Certificate, COA, COC, stability data, dissolution profiles — is pre-prepared for state tender and CGHS/ESIC bid submission. For export registration in African and South-East Asian markets, complete dossier support is provided.

Available Dosage Forms

Cardiovascular formulations
across 3 dosage forms

Our cardiovascular range covers oral solid and sterile injectable dosage forms — matching hospital formulary, institutional supply and critical care requirements.

Tablets
- Standard
- Film-coated
- Extended-release
- Fixed-dose combinations
- Antihypertensives
- Diuretics
- Lipid-lowering
- Beta-blockers
- Amlodipine
- Atenolol
- Metoprolol
- Atorvastatin
- Furosemide
- Warfarin
Capsules
- Hard gelatin
- Immediate-release
- Antihypertensives
- Anticoagulants
- Lipid-lowering
- Amlodipine capsules
- Rosuvastatin capsules
- Anticoagulant capsules
Injections
- Vial liquid
- Ampoule
- SVP sterile
- Antihypertensives
- Antiarrhythmics
- Anticoagulants
- Labetalol
- Adenosine
- Heparin

Why Choose Us

Why choose 9M India for
cardiovascular drug manufacturing

Cardiovascular medicines require long-term supply reliability — hospital formularies cannot afford stockouts on antihypertensive or cardiac emergency medications. 9M India provides the supply consistency, documentation depth and manufacturing compliance that institutional cardiovascular procurement demands.

Oral and sterile injectable. One cardiovascular manufacturer.

Antihypertensive tablets, statin film-coated tablets and critical care cardiac injectables — Labetalol, Adenosine, Heparin — manufactured in the same 9M India group facility. Single- source supply from formulary essentials to emergency cardiac medications.
Low-dose antihypertensive manufacturing. Enhanced validation.

Amlodipine at 2.5mg and 5mg strengths requires enhanced blend uniformity validation — not standard content uniformity testing. 9M India applies enhanced stratified sampling and blend uniformity assay protocols for all cardiac formulations at low dose strengths. This is the technical standard institutional buyers need to see.
Statin packaging. Alu-Alu as standard.

Atorvastatin and Rosuvastatin are moisture and light sensitive. We use Alu-Alu cold form blister as the standard packaging for all statin formulations — not as an upgrade option. Shelf-life compliance is built into the manufacturing and packaging process, not managed after the fact.

Our Cardiovascular Range

Key cardiovascular formulations
manufactured at 9M India

9M India offers diverse tablet variaCore cardiovascular molecules from our manufacturing portfolio — across antihypertensives, lipid-lowering agents, diuretics, antiarrhythmics and anticoagulants.nts designed for reliable performance, quality assurance, and fulfilling therapeutic requirements.

01

Amlodipine | Antihypertensive | Standard tablet | Calcium channel blocker
02

Atenolol | Antihypertensive | Standard tablet | Beta-blocker
03

Metoprolol | Antihypertensive | Standard / ER tablet | Beta-blocker
04

Losartan | Antihypertensive | Film-coated tablet | ARB
05

Furosemide | Diuretic | Standard tablet | Loop diuretic
06

Hydrochlorothiazide | Diuretic | Standard tablet | Thiazide diuretic
07

Atorvastatin | Lipid-lowering | Film-coated tablet | Statin
08

Rosuvastatin | Lipid-lowering | Film-coated tablet | Statin
09

Warfarin | Anticoagulant | Standard tablet | Vitamin K antagonist
10

Labetalol Injection | Antihypertensive | Ampoule · Sterile | Alpha + Beta blocker
11

Adenosine Injection | Antiarrhythmic | Vial liquid · Sterile | Antiarrhythmic
12

Heparin Injection | Anticoagulant | Vial liquid · Sterile | Anticoagulant

We keep answer short

Frequently asked questions —
cardiovascular drug manufacturing

Frequently asked questions in tablet manufacturing address processes, quality standards, formulation methods, regulatory compliance, and production capabilities, helping clients.

01

9M India manufactures antihypertensives (calcium channel blockers, beta-blockers, ARBs), diuretics (loop, thiazide, potassium-sparing), lipid-lowering agents (statins), anticoagulants and antiarrhythmics — across tablets, capsules and sterile injectable formats.
02

Yes — Labetalol injection (antihypertensive), Adenosine injection (antiarrhythmic) and Heparin injection (anticoagulant) — all manufactured as Small Volume Parenterals in classified cleanroom environments with sterility, endotoxin and particulate matter testing on every batch.
03

Atorvastatin and Rosuvastatin tablets across multiple strengths — film-coated, packaged in Alu- Alu cold form blister as standard. Full stability data under ICH conditions available for all statin formulations.
04

Yes. Antihypertensives and diuretics are core items on state essential medicines lists and CGHS/ESIC formularies. Our DCGI-approved cardiovascular formulations are supported by complete documentation pre-prepared for institutional tender bid submission.
05

Yes — fixed-dose combinations including Amlodipine + Atenolol and Amlodipine + Valsartan. Combination tablets are validated for content uniformity of both active components with individual and combined dissolution testing.